Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 13,855,982 $ 21,531,665
Other receivables 785,000 0
Prepaid expenses and other current assets 389,461 172,460
Total Current Assets 15,030,443 21,704,125
Other Assets    
Trademarks 100,217 85,562
Total Assets 15,130,660 21,789,687
Current Liabilities    
Accounts payable and accrued liabilities 539,095 382,130
Accrued legal settlement costs 675,000 4,200,000
Total Current Liabilities 1,214,095 4,582,130
Stockholders' Equity    
Preferred stock value 0 0
Common stock, $0.001 par value, 13,500,000 shares authorized, 6,595,503 shares and 6,567,110 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively 6,595 6,567
Additional paid-in capital 146,684,313 146,353,232
Accumulated deficit (132,777,693) (129,155,608)
Total Stockholders' Equity 13,916,565 17,207,557
Total Liabilities and Stockholders' Equity 15,130,660 21,789,687
Convertible Series A Preferred Stock [Member]    
Stockholders' Equity    
Preferred stock value 683 699
Convertible Series B Preferred Stock [Member]    
Stockholders' Equity    
Preferred stock value $ 2,667 $ 2,667